The US Food and Drug Administration has approved two new breakthrough therapies for patients with sickle cell disease (SCD), and we believe both may enhance the treatment of our patients here at CHOP.
Read morePublished on in Community Benefit Report
CHOP volunteers make camp a reality for many kids with special medical needs. They not only keep them healthy, but they also take part of the activities and enjoy seeing kids being kids.
Published on in CHOP News
Born with sickle cell disease, Naomi receives breakthrough treatments and screenings at CHOP to keep her symptoms in check and protect her from strokes.
Published on in CHOP News
Researchers have found a key protein that could become a target for a new treatment for sickle cell disease. In lab tests, blocking the protein reduces sickling that distorts red blood cells.
Published on in CHOP News
Proceeds support sickle cell research and patient care at Children’s Hospital of Philadelphia.
Published on in CHOP News
The Children's Hospital of Philadelphia’s 15th annual Blue Tag Gala raised more than $150,000 to support patient care and cutting-edge research at the hospital’s Comprehensive Sickle Cell Center
Published on in CHOP News
The journal Nature interviews Alan Flake, MD, about his research into the use of in utero stem-cell transplantation to cure sickle cell disease.
Published on in CHOP News
Psychologists at CHOP have developed an evidence-based coping tool for children with sickle cell disease and their families called The Cellie Coping Kit.
Published on in CHOP News
CHOP scientists altered red blood cells to produce a form of hemoglobin not affected by the mutation that causes sickle cell disease. The findings may lead to a new therapy for the disease.
Published on in CHOP News
CHOP Hematology researchers manipulated red blood cells in the lab to produce a healthy form of hemoglobin — a potential treatment for sickle cell disease.